Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.
Jerlene Xie never thought that signing up for the Bone Marrow Donor Programme would result in a call from the registry five years later saying she was a match for an elderly man with leukaemia. She ...
Good afternoon and welcome to SI-BONE third-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the ...